I-Sitagliptin Phosphate Monohydrate ePhakathi CAS 486460-21-3 Ubunyulu > 99.0% (HPLC) Umzi-mveliso oPhezulu oPhezulu

Inkcazelo emfutshane:

Igama leKhemikhali: 3-(Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride

CAS: 486460-21-3

Ubunyulu: >99.0% (HPLC)

Imbonakalo: Umgubo oMhlophe ukuya kokuKhanyayo oMthubi

I-Intermediate ye-Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) yonyango lwe-II diabetes mellitus

E-Mail: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Iipropati zeMichiza:

Igama leMchiza 3-(Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride
Izithethantonye I-Sitagliptin Phosphate Monohydrate ePhakathi
Inombolo yeCAS 486460-21-3
Inombolo yeCAT RF-PI1194
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli C6H7F3N4
Ubunzima beMolekyuli 192.14
Indawo yokubilisa 266℃
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Umgubo oMhlophe ukuya koMthubi oKhanyayo
Ukuchongwa I-spectrum yokufunxa ye-UV yesampulu eqhelekileyo ibonisa ubuninzi &ubuncinane kumaza amaza afanayo
Ukuchongwa I-HPLC: Ixesha lokugcinwa okufanayo
Ilahleko ekomisweni <2.00%
Ukungcola Okuqhelekileyo <1.00%
Ubunyulu / Indlela yokuHlalutya >99.0% (HPLC)
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa Umbindi weSitagliptin Phosphate Monohydrate (CAS: 654671-77-9)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-3-(Trifluoromethyl) -5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride (CAS: 486460-21-3) iphakathi kweSitagliptin Phosphate Monohydrate ( I-CAS: 654671-77-9) yonyango lwe-type II yesifo sikashukela.I-Sitagliptin ivunyiwe yi-FDA njengenxalenye yokutya kunye nokuzilolonga ukuphucula ulawulo lwe-glycemic kwizigulane ezine-T2DM, mhlawumbi njenge-monotherapy, okanye idibene ne-Metformin okanye i-peroxisome proliferatoractivated receptor-γ agonist (umzekelo, i-thiazolidinediones) xa i-arhente enye. ayiboneleli ngolawulo olwaneleyo lwe-glycemic.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi